Moderna made the mRNA COVID vaccine, developing cancer and flu shots.
Moderna, Inc. (MRNA) is expected to report earnings on Friday, November 6, 2026, before the open. Estimated release time 07:01 ET. Consensus EPS estimate is $-1.10.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-31 | Jun 2026 qtr | $-2.03 | $-1.97 | +3.0% | $145.00M |
| 2026-05-01 | Mar 2026 qtr | — | $-3.40 | — | $389.00M |
| 2026-02-13 | Dec 2025 qtr | $-2.54 | $-2.11 | — | $678.00M |
| 2025-11-06 | Sep 2025 qtr | $-1.87 | $-0.51 | — | $1.02B |
| 2025-05-01 | Mar 2025 qtr | $-2.92 | $-2.52 | +13.7% | $107.00M |
| 2025-02-14 | Dec 2024 qtr | $-2.68 | $-2.50 | +6.7% | $956.00M |
| 2024-11-07 | Sep 2024 qtr | $-1.91 | $0.03 | — | $1.85B |
| 2024-08-01 | Jun 2024 qtr | $-3.35 | $-3.33 | +0.6% | $241.00M |
MRNA has beaten consensus EPS in 4 of its last 4 scored quarters.
See MRNA on the live calendar →